Introduction
The observation that skeletal muscle has the capacity to regenerate after injury was well documented by microscopic examination in the mid -19 th century, primarily in German literature (Scharner and Zammit, 2011) . Still, the cellular basis of this regenerative potential remained elusive for a century until 50 years ago when Alexander Mauro detected a mononucleated cell, which he termed a ''satellite cell,'' closely apposed to mature myofibers in electron micrographs of skeletal muscle . Without any functional evidence, he hypothesized that this could represent a kind of muscle progenitor cell akin to those present in the developing embryo, capable of forming new muscle in response to injury. This turned out to be a very accurate prediction: five decades of research on satellite cells have demonstrated that they have the characteristics that Mauro surmised. In modern parlance, the satellite cell is considered a muscle stem cell distinguished from the plethora of adult tissue-specific stem cells that have been described by the fact that it was identified anatomically before it was characterized functionally; most adult stem cells have been first demonstrated to exist in functional assays, which are then followed by a hunt for the cells histologically. The history of the satellite cell has been the subject of several recent reviews (Scharner and Zammit, 2011; Yablonka-Reuveni, 2011) , and the regulation and contribution of satellite cell progenitors during lineage progression, differentiation, and contribution to muscle repair has also been extensively documented (Chargé and Rudnicki, 2004; Wang and Rudnicki, 2012; Zammit et al., 2006) . In this review, we focus on the current status of satellite cell research through the lens of stem cell biology. We highlight recent studies illustrating that satellite cells are essential for maintenance of the stem cell pool and repair of the differentiated muscle tissue in which they reside. In addition, we discuss the properties that satellite cells possess in common with other stem cell populations and the mechanisms that regulate satellite cell functions.
Satellite Cell Identification and Stem Cell Properties
After anatomical identification of satellite cells in 1961, their behavior in response to growth and regeneration was investigated. It was noted that in regenerating muscle, undifferentiated cells increase in abundance and align with the periphery of damaged fibers. As regeneration progresses, immature myogenic progenitors are replaced with more mature myoblasts (Allbrook, 1962) . At later stages of repair, undifferentiated cells begin to appear in association with the regenerated fibers (Shafiq and Gorycki, 1965) . A series of studies using tritiated thymidine confirmed that satellite cells were mitotically dormant in mature muscle and the source for regenerating muscle (Reznik, 1969; Snow, 1977) and that daughters of satellite cells contributed to both the satellite cell compartment and differentiated nuclei in growing muscle Moss and Leblond, 1970, 1971; Schultz, 1996) . Thus with the evidence that satellite cells were capable of asymmetric divisions and endowed with self-renewal properties, a new era was born, in which satellite cells were considered bona fide MuSCs.
Cell transplantation was becoming more commonplace in regenerative biology to test cellular contribution to tissue repair and renewal of progenitor populations. The grafting of committed satellite cell progeny (myoblasts) between mice with different isoenzyme subtypes confirmed that donor cells could fuse with host cells or myofibers (Partridge et al., 1978; Watt et al., 1982) , providing evidence of a renewable cell source with regenerative capacity. However, identification and isolation of the self-renewing cells, MuSCs, remained elusive for many years.
Eventually, immunotypic analysis identified the paired box 7 transcription factor Pax7 as a uniform marker of satellite cells . In response to injury, Pax7 + satellite cells enter cycle and differentiate and a subset returns back to quiescence to replenish the dormant satellite cell pool (Abou-Khalil and Brack, 2010) . A body of work during the late 1980s and early 1990s discovered the family of myogenic regulatory factors (MRFs), including Myod, Myf5, Mrf44, and Myogenin, genes that coordinate developmental myogenesis (Bentzinger et al., 2012) . In their quiescent state, adult satellite cells express, along with Pax7, the Myf5 transcript but lack Myod. During activation and lineage progression, satellite cells turn on Myod and Myf5 protein, followed by the marker of terminal differentiation, Myogenin (Chargé and Rudnicki, 2004) . Demonstration of a tractable muscle-resident cell that contributed to muscle fiber repair and repopulation of the niche was achieved through transplantation of a FACS-isolated subset of muscle-resident cells selected via cell surface receptor expression (such as CD31
À , CXCR4 + , CD31 + ,
Integrin b1 + ) Sherwood et al., 2004) . Engrafting a single myofiber with its satellite cells marked by a nuclear Myf5 lacZ reporter provided the first definitive demonstration that satellite cells possess stem cell activity . In recent years, satellite cells have been proven to self-renew at the single-cell level (Sacco et al., 2008) and to retain stem cell function over seven rounds of serial transplantation and therefore function as MuSCs (Rocheteau et al., 2012) . With the advent of conditional Cre/lox systems, lineage tracing of satellite cells has demonstrated that adult Pax7 + cells selfrenew and differentiate in their endogenous environment in response to injury Shea et al., 2010) , suggesting that adult Pax7 + satellite cells are sufficient for both
MuSC pool maintenance and myofiber repair. Moreover, studies using inducible genetic strategies to ablate adult Pax7 + cells have demonstrated that satellite cells are essential for muscle repair and replenishment of the MuSC pool McCarthy et al., 2011; Murphy et al., 2011; Sambasivan et al., 2011) . Cre/lox technology has also enabled the assessment of lineage potential of satellite cells. Based on studies with Pax7
CreERTM and Myod
Cre , it appears that most if not all satellite cells are restricted to the myogenic lineage, arguing in favor of unipotency of adult satellite cells Shea et al., 2010; Starkey et al., 2011) . However, it appears that at least a subset of satellite cells are driven out of lineage, becoming fibrogenic in pathological conditions or during aging (Amini-Nik et al., 2011; Brack et al., 2007) .
Although the contribution of satellite cells to tissue repair is indisputable, their role in other aspects of skeletal muscle biology is less certain (Figure 1 ). During normal daily activity, muscle fiber size and myonuclear content remain relatively constant throughout most of adult life (Hughes and Schiaffino, 1999) , and satellite cells may exhibit a modest decline depending upon the specific muscle and species examined (Brack and Rando, 2007) . Are satellite cells participating to maintain muscle fibers during homeostasis? Indelible-marked adult satellite cells chased over 6 weeks do not appear to undergo proliferation or contribute to muscle fibers Shea et al., 2010) . Moreover, 2 weeks after ablation of the satellite cell pool by a genetic strategy, muscle fiber size appears unaffected . Even 6 months after depletion of satellite CreERTM.R26Rb-gal is shown by X-gal reaction on an adult lower limb muscle prior to and after injury (reproduced from Shea et al., 2010) . Note the many X-gal + muscle fibers running throughout the regenerating muscle. (C) Pax7 + cells located in satellite cell position in uninjured muscle and their contribution to both myofiber repair and repopulation in the satellite cell position after regeneration (reproduced from Shea et al., 2010) . (D) A schematic showing the participating roles of satellite cells. Pax7-expressing satellite cells (red) reside between the plasmalemma (brown line) of the muscle fiber and the basal lamina (black line). A mature adult muscle contains thousands of differentiated nuclei (green) and $10 SCs (this number is highly dependent on age, muscle length, and metabolic character). In response to injury, Pax7 + cells proliferate, most differentiate and fuse to regenerate myofibers (blue), whereas a minority self renew and return back to quiescence to replenish the satellite cell pool (left). After genetic ablation of satellite cells, muscle regeneration is prevented. During rapid hypertrophic stimuli, satellite cells fuse to add differentiated myonuclei. After genetic ablation of satellite cells, muscle hypertrophy occurs without addition of myonuclei, suggesting that satellite cells are dispensable for protein accumulation and hypertrophy (center). During normal tissue homeostasis, the contribution of satellite cells to maintenance of tissue or the satellite cell pool remains unknown (right).
cells from a muscle, gross histological appearance is normal and fiber size changes negligibly (Cheung et al., 2012) . Together, the data suggest that satellite cell contribution to myofiber maintenance is minimal during homeostasis. It would be informative to determine whether ablation of the adult pool would exacerbate muscle atrophy in contexts of higher cellular demand such as exercise or aging.
Adult skeletal muscle is capable of hypertrophy, and the question as to satellite cell participation in that process has been debated for many years. Recent studies have provided direct evidence of hypertrophy without any satellite cell contribution. Using a genetic strategy to ablate the adult Pax7 + cell pool, mice deficient in satellite cells were able to rapidly increase muscle fiber size during a 2 week hypertrophic stimulus . This occurred in the absence of satellite cell-derived myonuclear accretion, suggesting that satellite cells are dispensable for increase in muscle mass. However, it is possible that over longer periods of time, additional differentiated nuclei, and hence a maintained myonuclear domain size in hypertrophic muscle, would be required to maintain a larger muscle fiber (Hughes and Schiaffino, 1999) . This is supported by the fact that loss of differentiated nuclei in aged muscle fibers precedes muscle fiber atrophy (Brack et al., 2005) .
Stem Cell Characteristics Developmental Origins
Based on anatomical position and expression of Pax7, satellite cell precursors first appear during late fetal stage (Relaix et al., 2004 . Lineage tracing approaches demonstrated that the majority of adult Pax7 + satellite cells are formed from a somitic origin of cells that transition through a Pax7 +/ Myod + state (Kanisicak et al., 2009; Lepper and Fan, 2010; Schienda et al., 2006) . It is clear that the number of Pax7 + cells declines during development and postnatal growth (Schultz, 1989; White et al., 2010) . Therefore, not all embryonic Pax7 + cells will form the self-renewing adult pool, but instead some will primarily contribute to the growing myofiber. This suggests that some fetal Pax7 + /Myod + cells differentiate and other Pax7 + /Myod + cells form the adult satellite cell pool. Myod is considered a master regulator of myogenesis (Weintraub et al., 1991) . Based on germline mutants, Myod is required for satellite cell differentiation but not for the formation of the satellite cell pool (Chargé et al., 2008; Rudnicki et al., 1992) . In vitro experiments demonstrate that subsets of myogenic progenitors lose Myod and return to a quiescent state (Halevy et al., 2004; Yoshida et al., 1998; Zammit et al., 2004) . Moreover, selfrenewing adult satellite cells transiently express Myod prior to niche repopulation during repair (Shea et al., 2010) . Therefore, Pax7 + /Myod + precursors are able to form the satellite cell pool providing that Myod is repressed. Based on studies with a Myf5
CreYFP reporter, it was demonstrated that the majority (90%) of the adult satellite cell pool is formed from a Myf5 + precursor . However, the formation of the satellite cell pool in germline Myf5 nulls suggests that Myf5 is not required for satellite cell formation; compensation by Myod cannot be excluded (Gensch et al., 2008; Haldar et al., 2008) . While there are multiple caveats to consider when interpreting these studies, including the contribution of non-Cre-recombined cell populations, these results suggest that the adult satellite cell pool is formed from precursors that are under different transcriptional control. Contribution from the extrinsic environment may also participate in differential regulation of satellite cell precursors. While the adult satellite cell pool is formed from Pax7 + embryonic precursors, this does not preclude a model whereby an alternative source of cells express Pax7 and home to the satellite cell niche. Using immunotypic markers (CD34 + /Sca1 + ) in combination with donor cell marking for transplantation studies, it has been demonstrated that a subset of PICs (PW1 + Pax7
À interstitial cells) self-renew and contribute to myofibers and Pax7 + satellite cells in injured adult muscle . Moreover, myogenic contribution of PICs was Pax7 dependent and temporally restricted to postnatal growing muscle. Based on lineage tracking, a subset of alkaline phosphatase (AP)-expressing pericytes indelibly marked in postnatal mice contributed to the formation of the adult Pax7 + satellite cell compartment (Dellavalle et al., 2011) . Therefore the origin of the adult satellite cell pool may be heterogeneous ( Figure 2 ). In the future, it will be important to dissect the unique properties and lineage relationship between pericytes and PICs that express Pax7 relative to Pax7-derived satellite cells.
Asymmetric Cell Divisions
While asymmetric cell divisions are one of the fundamental characteristics of stem cells underlying the process of self-renewal, stem cells may undergo self-renewal by virtue of symmetric divisions (Tajbakhsh et al., 2009) . As long as only one daughter of a symmetric cell division is instructed to differentiate, the stem cell pool can be maintained while differentiated progeny are produced. Historically, there were no seminal observations that provided evidence to either support or refute asymmetric cell divisions in the satellite cell lineage, and it was only in the past decade that this has been the focus of studies in the MuSC field. The first evidence of asymmetric cell divisions came from studies of the role of Notch signaling during satellite cell activation and proliferative amplification. It was found that the Notch inhibitory protein Numb was asymmetrically segregated in progenitors undergoing cell division and that Numb was localized . This asymmetric Numb localization is reminiscent of what had been previously described in specific lineages during Drosophila development (Petersen et al., 2002; Zhong et al., 1996) . The result of such an asymmetric segregation in the satellite cell lineage is the inheritance of Numb by one daughter and not the other, the former being destined to differentiate and the latter remaining an undifferentiated progenitor . The asymmetric segregation of Numb was subsequently investigated during satellite cell activation, and asymmetric segregation of Numb was also detected in cells prior to the onset of differentiation (Shinin et al., 2009) . Other proteins, such as Myod and Dek (Cheung et al., 2012) , are asymmetrically segregated in activated satellite cells, and those proteins are more highly expressed in cells that have progressed further along the myogenic lineage. Asymmetric cell divisions have also been suggested in relation to the aforementioned distinction of satellite cell subsets based on developmental history of Myf5 expression . In this model, satellite cells undergo asymmetric cell divisions, giving rise to two daughters, one being another stem cell (still with no history of Myf5 gene expression) and the other becoming part of the larger pool of satellite cells (and expressing the Myf5 transcript). In this case, there is no direct evidence as yet of an asymmetric segregation of any specific protein or transcript in the mother cell, and the asymmetry may instead be a divergent cell fate dictated by the different environments of the two daughters. This is particularly likely given the observation that daughters exhibiting divergent fates, one self-renewing and the other committing toward differentiation, were much more frequent when the plane of division was perpendicular to the axis of the myofiber . By contrast, divisions that occurred parallel to the myofiber axis were much more likely to give rise to two daughters with identical characteristics as opposed to divergent fates, suggesting that the local environment of the satellite cell niche might be dictating the fate of satellite cell progeny.
Yet another asymmetry that has been described is the asymmetric segregation of sister chromatids as satellite cells divide and the population expands (Conboy et al., 2007; Shinin et al., 2006) . Recent evidence suggests that a subset of satellite cells, in fact those with characteristics of long-term stem cells, are more likely to exhibit nonrandom sister chromatid segregation (Rocheteau et al., 2012) . This further supports the notion that asymmetric segregation of sister chromatids might be a property of stem cells as originally proposed (Figure 3; Cairns, 1975) . Although the functional significance of this remains theoretical, the proposed function is to segregate DNA strands that have been damaged during replication to the more differentiated daughter and reserve for the self-renewing stem cells those strands that served as templates during the previous round of cell division, thus acquiring few replication-induced errors (Charville and Rando, 2011) . Although this teleological function has not been demonstrated and there may be detrimental consequences of template strand segregation during aging (Charville and Rando, 2011) , it is supported by the fact that the oldest template strands segregate with the less differentiated satellite cell daughter (Conboy et al., 2007; Shinin et al., 2006) . Satellite Cell Heterogeneity It is becoming more apparent that adult stem cell populations are heterogeneous. Heterogeneity in the adult satellite cell pool has been demonstrated based on multiple criteria, such as expression profile Rocheteau et al., 2012) , proliferation kinetics in vitro (Day et al., 2009) , self-renewal potential , and molecular regulation (Kitamoto and Hanaoka, 2010; Shea et al., 2010) . Functional heterogeneity within a pool of adult stem cells can arise from differentially specified subsets that retain distinct properties during cellular division or evolution of a subset of cells derived from a single homogeneous cell population that will emerge during cellular division.
It is widely accepted that Pax7 expression declines in differentiating progenitors . Evidence for varied Pax7 levels within the satellite cell pool was recently demonstrated via a transgenic GFP reporter of Pax7 transcript (Rocheteau et al., 2012) . Functional analysis of satellite cells at extreme ends of the Pax7 expression distribution demonstrated that Pax7 hi cells had reduced metabolic activity and slower cell cycle entry kinetics, whereas Pax7 lo cells were primed to differentiate in vitro. Although cells with lower Pax7 expression appeared to be more prone to differentiation, all Pax7 + cells could support more than six serial transplantations, demonstrating that both subsets of satellite cells possess remarkable regenerative capacity and the ability to self-renew. Using an inducible Cre/ lox system, Pax7 was deleted from satellite cells in growing postnatal muscle and adult muscle prior to injury. The results . Given that a subset of postnatal Pax7 + cells seeds the adult Pax7 + pool, it supports the hypothesis that there is a small subset of postnatal Pax7 + cells that evolve during the selective pressure of muscle growth to propagate satellite cells that function independently of Pax7. It raises the possibility that functionally distinct satellite cell subsets can interconvert for selective advantage under conditions of high cellular demand as observed in spermatogonial stem cells (Nakagawa et al., 2007 (Nakagawa et al., , 2010 .
Adult stem cells with limited proliferative history are endowed with greater stem cell capability than more frequently dividing counterparts (Foudi et al., 2009; Wilson et al., 2008) , suggesting that stem cell self-renewal capacity may decline in proportion with the number of divisions a stem cell has undergone in its history. Interestingly, subsets of presumptive satellite cells in growing postnatal muscle divide with slower proliferation kinetics, based on tritiated thymidine uptake (Schultz, 1996) . These data suggest that one level of functional heterogeneity in the satellite cell pool may exist based on their proliferative history. In dystrophic muscle, disease progression correlates with proliferative capacity of satellite cells, suggesting that restricting proliferative output of stem cells relative to their downstream progeny may extend self-renewal capacity and ameliorate disease pathogenesis . Whether functional heterogeneity across a pool of satellite cells is stable once specified or adaptive based on cellular demand, it is clear that the satellite cell pool is functionally heterogeneous. The challenge in the future is to determine how molecular heterogeneity at the cell-intrinsic and -extrinsic levels instructs functional diversity within the satellite cell pool.
Regulation of Satellite Cell Function Stem Cell Niche
The stem cell niche refers to the microenvironment that maintains ''stemness' ' (Schofield, 1978) . The attributes of the niche as originally conceptualized were (1) a defined anatomical site, (2) a location where stem cells could reproduce, (3) a place where differentiation is inhibited, and (4) a space that also limits the numbers of stem cells. Therefore, the niche is a protector of stem cell number and function, restraining proliferation and differentiation of stem cells, and maintaining a quiescent phenotype.
The location of the satellite cell, i.e., residing in a depression in the plasmalemma and beneath the basal lamina of the muscle fiber, provided a defined anatomical site of the putative MuSC . The hypothesis that the muscle fiber is a satellite cell niche is supported by evidence generated from single muscle fiber experiments. Removal of the myofiber plasmalemma drives quiescent satellite cells into cycle, suggesting a role in inhibition of mitogen-induced cell cycle entry (Bischoff, 1986a) . Quiescence is a conserved property of stem cells mediated by the niche (Orford and Scadden, 2008) . Studies on freshly isolated single muscle fibers have shown that a subset of quiescent satellite cells can proliferate and return back to quiescence when in contact with the single muscle fiber, whereas a larger subset commits to differentiation but their fusion is inhibited (Bischoff, 1986a; Zammit et al., 2004) .
Therefore the muscle fiber fulfills three of Schoffield's criteria of a stem cell niche. Whether the muscle fiber constrains stem cell numbers is to be determined.
In response to injury, the muscle fiber degenerates, which probably leads to niche destruction and a loss of inhibitory signals. Besides losing inhibitory factors that restrict proliferation and differentiation from the degenerated niche, muscle injury also promotes the release of stimulatory factors present at the basal lamina of the muscle fiber that drive proliferation and differentiation (Bischoff, 1986b; Sheehan and Allen, 1999) . The observation that microenvironment stiffness is a regulator of stem cell potential and fate decisions suggests that maintenance of stemness from the niche is regulated at many levels (Engler et al., 2006; Gilbert et al., 2010) . Resolving the signals that drive self-renewal versus differentiation will require a careful characterization of the basal and apical aspects of the niche ( Figure 4A ).
The satellite cell niche may be composed of different cell types, as observed for other stem cell compartments (Morrison and Spradling, 2008) . Besides the muscle fiber, there are other muscle-resident cells in close proximity to the satellite cell, such as Ang1-expresssing endothelial cells (Abou-Khalil et al., 2009; Christov et al., 2007) . It is becoming clear that other cell types, such as fibro-adipogenic progenitors (FAPs) and TCF4 + fibroblasts, influence satellite cell behavior in contexts of regeneration and growth Murphy et al., 2011) . It remains to be determined whether such cell types constitute the niche and therefore regulate stemness or function as paracrine agents involved in proliferation and differentiation of satellite cell progeny ( Figure 4A ). As cell-specific Cre drivers become more readily available, it will be possible and essential to determine the cell types and mode of regulation that contribute to a functional satellite cell niche. Signaling Pathway Regulation of Satellite Cell Function A balance between extrinsic cues and intracellular signals converge to preserve stem cell function. Over the past 50 years, many excellent studies have demonstrated that multiple extrinsic signaling pathways, such as IGF, FGF, Wnt, Notch, BMP, and TGF-b, function in the activation of satellite cells, their downstream progeny, and their lineage progression . More recently, the signaling pathways that modulate functions specific to stem cells, such as maintenance of quiescence during homeostasis, reversible quiescence and self-renewal after proliferation, asymmetric fate decisions, and symmetric expansion of stem cells, are becoming more defined ( Figure 4B) .
It was recently shown that active Notch signaling is required to maintain satellite cells in the quiescent state, implying a role of niche-derived Notch ligand that binds to a Notch receptor on the quiescent satellite cell Mourikis et al., 2011) . In these studies, Rbp-j, the downstream transcriptional coactivator in the Notch pathways, was deleted from adult satellite cells in uninjured muscle. This led to activation and ectopic differentiation of satellite cells, possibly in the absence of cell cycle entry and therefore bypassing the transient amplifying (TA) progenitor stage Mourikis et al., 2011) . Therefore, not only is RBP-J important for restricting cell cycle entry, it also argues that in nonquiescent satellite cells, RBP-J, possibly as a mediator of Notch1 signaling, may be required for normal step-wise lineage progression . That the satellite cell pool is lost when the TA stage is bypassed has implications for understanding the relationship between self-renewal and differentiation potential of downstream progenitors within the stem cell hierarchy.
To replenish the satellite cell pool after injury, stem cells return back to quiescence after proliferating. Our understanding of reversion back to quiescence in vivo is limited. Based on in vitro experiments it is becoming apparent that multiple signaling pathways are actively involved in promoting satellite cell quiescence. Activation of the Ang1/Tie2 signaling complex promotes the return to quiescence of myoblasts in vitro (AbouKhalil et al., 2009) . P38/MAPK pathway has also been implicated in regulating quiescence of satellite cells (Jones et al., 2005) . Finally, Myostatin, a secreted growth factor belonging to the TFG-b family, was shown to negatively regulate quiescence and the return to quiescence of satellite cells in vitro McFarlane et al., 2008) . Together these data illustrate a critical role of growth factor signaling in the return of cycling satellite cell progenitors back to a quiescent state. Further in vivo analysis and genetic approaches that directly target satellite cells will clarify the signaling cascades that regulate the maintenance of quiescence and return to quiescence after proliferation.
Recently, signaling through Notch-3 was found to negatively regulate satellite cell pool size in regenerating muscle (Kitamoto and Hanaoka, 2010) . Whether this is regulated at the cellautonomous level of the satellite cell or by a niche-based mechanism will require cell-specific genetic mutants. Using a satellite cell-specific mutant for Spry1, it was demonstrated that Spry1, an inhibitor of growth factor signaling, is required to restore satellite cell pool size after injury (Shea et al., 2010) . This suggests that a balance between inhibitory and stimulatory cues from the microenvironment is required for quiescence to be achieved. One can theorize that Spry1 and other intracellular growth factor inhibitors help to dampen the stimulatory factors at the basal lamina to direct fate toward quiescence and the repression of differentiation. The challenge in the future is to identify niche-derived inhibitory signals that promote and retain stemness after injury.
Stem cells possess a unique ability to divide symmetrically or asymmetrically depending on tissue requirements (Tajbakhsh et al., 2009) . Noncanonical Wnt signaling through the Wnt7A-Frz7-Vangl2 cascade was recently implicated in driving symmetric expansion of satellite cells located on single muscle fibers in vitro ). It will be interesting to unravel the relationship between asymmetric divisions via Numb and symmetric divisions via Wnt7A-Vangl2 that occur to control stem cell expansion and differentiation.
In general, the cellular output within a pool of cells in response to manipulation of signaling cascades is not equivalent. Through loss-of-function approaches, it has been demonstrated that satellite cells differentially respond to manipulation of signaling molecules such as Spry1 and Notch-3 (Kitamoto and Hanaoka, 2010; Shea et al., 2010) . It will be important to decipher whether heterogeneous cell signaling requirements are due to extrinsic differences, such as localization of satellite cells in discrete niches, or to cell-intrinsic differences, based on lineage relationships.
While knowledge of the signaling cascades that regulate stem cell properties of satellite cells is progressing, it is likely that more (Petersen et al., 2004) . Likewise, Numb may be important for satellite cell self-renewal and also, at a later stage of myogenic lineage progression, for regulating the divergent fates of proliferating progenitors Jory et al., 2009; Shinin et al., 2006) . Therefore, while canonical Wnt, FGF, and BMP signaling cascades participate in myogenic lineage progression and differentiation , it may be that they are also deployed in some fashion to direct MuSC properties.
Epigenetic Regulation of Satellite Cell Function
Based on what we know about extrinsic cues controlling stem cell function, the role of the stem cell niche cannot be underestimated. However, more stable modes of regulation may also maintain key functions of satellite cells. Control of the function of stem cells, particularly embryonic stem cells (ESCs), has focused on regulatory mechanisms at the level of epigenetics, namely the ensemble of heritable changes in gene function that occur without modifications of the primary DNA sequence (Bird, 2007) . Such changes include DNA methylation and chromatin structural modifications mediated by histone modifications and nucleosome positioning. Not too long after the identification of the satellite cell, electron micrographs demonstrated that there are changes in chromatin organization in satellite cells from adult muscle and growing muscle consistent with their transition from a quiescent to a proliferative state (Church, 1969) . As our knowledge in the field of epigenetics becomes more sophisticated, it is becoming appreciated that the regulators of epigenetic states in stem cells include mediators of DNA methylation and demethylation, microRNAs and other noncoding RNAs, and modifiers of histones, including acetylases, deacetylases, methylases, and demethylases. This field is redefining cellular states at a molecular level that are much more varied and complex and probably reflect the dynamic interaction of stem cells with their environment resulting in greater functional heterogeneity than was previously envisioned.
It is likely that epigenetic states will better define such key satellite cell features as prolonged quiescence and lineage fidelity. It is also likely that DNA and histone modifications will underlie many of the changes in aged satellite cells that account for age-related declines in functionality and rejuvenation through exposure to the systemic environment (Brack et al., 2007; Conboy et al., 2005) . Although there has been extensive research on the epigenetic control of myogenesis, primarily using the C2C12 myoblast cell line (Juan et al., 2011) , studies in satellite cells have been limited because of the need for large numbers of cells for such analysis. Advances in both satellite cell purification and methodologies for genome-and epigenome-wide analyses of limited cell numbers will allow for rapid advances in these areas in the coming years.
There have, however, been studies of regulators of epigenetic states in satellite cells. It was shown that Pax7 functions with the Wdr5-Ash2L-MLL2 histone methyltransferase (HMT) complex to direct methylation of histone H3 lysine 4 (H3K4). Binding of the Pax7-HMT complex resulted in H3K4 trimethylation of chromatin at the Myf5 locus , suggesting that Pax7 may act through chromatin modifications to stably and hereditably maintain the myogenic program. Conversely, the regulation of Pax7 expression may be determined by the regulation of the repressive Polycomb repressive complex 2 (PRC2) and its enzymatic component, EZH2 (Palacios et al., 2010) , suggesting a network providing stability of the myogenic program related to Pax7 expression.
The regulation of myogenesis by microRNAs has likewise focused mainly on developmental myogenesis and the regulation of myogenic differentiation (Braun and Gautel, 2011) . Recent studies have also examined the role of miRNAs in the regulation of quiescent satellite cells. miR-206 was recently shown to target Pax3 in quiescent satellite cells, accounting for the differential expression in Pax3 in cellular subsets (Boutet et al., 2012) . This study also revealed that alternate polyadenylation of the Pax3 transcript is an important determinant not only of satellite cell heterogeneity but also of the susceptibility of the Pax3 transcript to regulation by any miRNA (Boutet et al., 2012) . Another micro-RNA, miR-489, was recently shown to be highly expressed in quiescent satellite cells and to regulate specifically the quiescent state by targeting the transcript of the Dek gene, a gene known to be important for cell cycle regulation and alternative splicing (Cheung et al., 2012) . Knockdown of miR-489 in vivo led to spontaneous activation of quiescent satellite cells, thus demonstrating the importance of a stable miRNA network for maintaining the quiescent state.
Conclusions and Perspectives
The last fifty years have led to a remarkable understanding of the satellite cell. It is widely accepted that the satellite cell is essential for regenerative myogenesis and can maintain itself after injury. It has been demonstrated that the muscle fiber constitutes a major functional component of the satellite cell niche. More recently, experiments have illustrated the functional heterogeneity within the satellite cell pool. As we move forward, what will the next fifty years bring?
Remarkably, we do not know whether satellite cells maintain themselves or differentiate to maintain muscle tissue during normal daily wear and tear. This information is critical as biologists devise strategies to harness skeletal muscle strength of the ever-expanding human aged population.
To date, direct experimental evidence is lacking to determine whether stem cell number is limiting. If MuSCs have a finite capacity, then a quorum will be required to functionally repair muscle tissue and maintain homeostasis. In the context of regenerating a tissue, such as skeletal muscle, it may be too simplistic to consider MuSC number and function as independent entities. Rather, there is probably a cooperative relationship between MuSC number and function in response to a regenerative insult. For example, in the presence of few MuSCs, a greater functional demand will be imposed on those rare cells, leading to their exhaustion. In contrast, increasing the number of MuSCs in a muscle will lessen the burden on each cell imposed by the regenerative insult. Technological advances in recent years have provided greater resolution of stem cell heterogeneity. With the advent of fluorescent reporters of proliferative history, it is now possible to isolate and compare such heterogeneous cells to dissect their function and molecular regulation (Foudi et al., 2009; Tumbar et al., 2004) . Marking satellite cells based on Cre drivers has proven invaluable for tracking them and their contribution to growth and repair (Lepper and Fan, 2010; Shea et al., 2010) . More recent advances through the use of multicolor Cre reporters or genetic barcoding utilized in other stem cell compartments have provided improved cellular resolution that facilitates the tracking of clonally diverse cells in a population to be studied (Lu et al., 2011; Snippert et al., 2010) . Such techniques reveal that the level of stem cell heterogeneity is more dynamic and context dependent than previously appreciated (Lu et al., 2011) . Information gleaned from such approaches will allow the relationship between molecular and functional heterogeneity to be resolved.
The anatomical location of the satellite cell provides a landmark for the satellite cell niche. Based on its conceptual framework, although the niche impacts stem cell properties of the satellite cell, the mechanism by which this is achieved remains a mystery. In the future, functional components of the satellite cell niche will be identified through technological advances in live imaging, microdissection, and biochemical analysis. As our understanding of satellite cell heterogeneity evolves, it will be interesting to identify whether there are distinct niches that, in some way, establish satellite cell heterogeneity. Advances in our knowledge of cell-intrinsic mechanisms that regulate stem cell function, such as epigenetic regulation of satellite cells, will illustrate the communication between the extrinsic environment and intrinsic effectors to specify and maintain stem cell states.
In conclusion, the seminal observations of the satellite cell in its niche made by Alexander Mauro almost fifty years ago have spawned many great advances in our understanding of this tissue-specific stem cell. It is apparent that there is greater heterogeneity in the satellite cell pool in terms of cellular subsets that specify the pool, their function, and the signaling cascades that regulate them. We are just beginning to unravel the microenvironmental influences that mediate stem cell properties and how epigenetic regulation governs stable properties of satellite cells during homeostasis and repair. Nakagawa, T., Nabeshima, Y., and Yoshida, S. (2007) . Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis. Dev. Cell 12, [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] Nakagawa, T., Sharma, M., Nabeshima, Y., Braun, R.E., and Yoshida, S. (2010) . Functional hierarchy and reversibility within the murine spermatogenic stem cell compartment. Science 328, 62-67. (1978) . The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4, 7-25. Schultz, E. (1989) . Satellite cell behavior during skeletal muscle growth and regeneration. Med. Sci. Sports Exerc. 21 (5, Suppl), S181-S186. Schultz, E. (1996) . Satellite cell proliferative compartments in growing skeletal muscles. Dev. Biol. 175, 84-94.
Schultz, E., Gibson, M.C., and Champion, T. (1978) . Satellite cells are mitotically quiescent in mature mouse muscle: an EM and radioautographic study. J. Exp. Zool. 206, 451-456.
Seale, P., Sabourin, L.A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., and Rudnicki, M.A. (2000) . Pax7 Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T.K., Turner, D., Rupp, R., Hollenberg, S., et al. (1991) . The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251, 761-766.
White, R.B., Bié rinx, A.S., Gnocchi, V.F., and Zammit, P.S. (2010) . Dynamics of muscle fibre growth during postnatal mouse development. BMC Dev. Biol. 10, 21.
Wilson, A., Laurenti, E., Oser, G., van der Wath, R.C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C.F., Eshkind, L., Bockamp, E., et al. (2008) . Hematopoietic stem cells reversibly switch from dormancy to selfrenewal during homeostasis and repair. Cell 135, 1118-1129.
Introduction
It has been known for more than a century that skeletal muscle, the most abundant tissue of the body, has the ability to regenerate new muscle fibers after it has been damaged by injury or as a consequence of diseases such as muscular dystrophy (1). Muscle fibers are syncytial cells that contain several hundred nuclei within a continuous cytoplasm. Therefore, whether the process of regeneration depends upon the fusion of mononucleated precursor cells or upon the fragmentation of dying muscle fibers, which release new cells, remained controversial for a long time, even after the demonstration by Beatrice Mintz and Wilber Baker (2) that multinucleated fibers are formed by the fusion of single cells. In 1961, Alexander Mauro (3) observed mononuclear cells between the basal lamina that surrounds each muscle fiber and the plasma membrane of the muscle fiber and named them satellite cells (SCs) (Figure 1 ). SCs were later accepted to be, and are still considered today, the main players in skeletal muscle regeneration. SCs also contribute to the postnatal growth of muscle fibers, which in adults contain approximately 6-8 times more nuclei than in neonates, all of them being irreversibly postmitotic.
In addition to SCs, other progenitors located outside the basal lamina, including pericytes, endothelial cells, and interstitial cells, have been shown to have some myogenic potential in vitro or after transplantation. The developmental origin of these progenitors is unclear, as is their lineage relationship with SCs, even though they may feed, to some extent, into the SC compartment (4) .
There is much interest in understanding the cellular and molecular mechanisms underlying skeletal muscle regeneration in different contexts because such knowledge might help in the development of cell therapies for diseases characterized by skeletal muscle degeneration. These diseases include muscular dystrophy, the term for a group of inherited disorders characterized by progressive muscle wasting and weakness leading to a variable degree of mobility limitation, including confinement to a wheelchair and, in the most severe forms, heart and/or respiratory failure (5) . Many muscular dystrophies arise from loss-of-function mutations in genes encoding cytoskeletal and membrane proteins, the most common and severe being Duchenne muscular dystrophy (DMD), which is caused by mutations in the gene encoding dystrophin, an integral part of a complex that links the intracellular cytoskeleton with the extracellular matrix in muscle. Muscular dystrophies are some of the most difficult diseases to treat, as skeletal muscle is composed of large multinucleated fibers whose nuclei cannot divide. Consequently, cell therapy has to restore proper gene expression in hundreds of millions of postmitotic nuclei (6) .
In this Review, we discuss recent work indicating the possible existence of a stem/progenitor cell compartment in adult muscle (see also ref. 7) as well as studies related to the derivation of myogenic cells from embryonic and induced pluripotent stem cells (PSCs) for the development of new cell therapy strategies for diseases of skeletal muscle. An overview of clinical trials based upon transplantation of skeletal muscle stem cells is also provided. Neither the role of SCs in aging skeletal muscle nor the SC niche are discussed here due to space constraints, and readers are directed to excellent recent reviews on these topics by Suchitra Gopinath and Thomas Rando (8) and Michael Rudnicki and colleagues (9), respectively.
SCs
Identification and characterization. The most stringent way to classify cells as SCs remains by determining their anatomical location: SCs are found underneath the basal lamina of muscle fibers, closely juxtaposed to the plasma membrane (3). SCs originate from somites (10, 11) , spheres of paraxial mesoderm that generate skeletal muscle, dermis, and axial skeleton, but the exact progenitor that gives rise to SCs remains to be identified. SCs are present in healthy adult mammalian muscle as quiescent cells and represent 2.5%-6% of all nuclei of a given muscle fiber. However, when activated by muscle injury, they can generate large numbers of new myofibers within just a few days (12) . Quiescent SCs (13) express characteristic (although not unique) markers. In the mouse, the most widely used of these markers is the transcription factor paired box 7 (Pax7) (14) , which is essential for SC specification and survival (15) . In contrast, Pax3 is expressed only in quiescent SCs in a few specific muscle groups such as the diaphragm (16) . The basic helix-loop-helix (bHLH) gene myogenic regulatory factor 5 (Myf5) is expressed in the large majority of quiescent SCs, and for this reason, mice expressing nuclear LacZ under the control of the Myf5 promoter (Myf5 nlacZ/+ mice) have been useful for identifying and characterizing SCs (17) . Many other markers (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) have been identified and are listed in Table 1 . Some of these surface markers are useful for isolating "purified" SC populations by cell sorting, but since each marker is not exclusively expressed on SCs, a combination of different markers must be used. Alternatively, transgenic mice such as those expressing GFP under the control of promoters that drive the expression of genes encoding SC markers - for example, the Pax3 promoter - can be used to isolate SCs (29) (30) (31) . In humans, markers of both quiescent and activated SCs do not fully correspond to those in the mouse, and relatively little is known about them due to the difficulty of obtaining human tissue. For example, although CD34 is a marker of SCs in mice, it does not mark SCs in human muscle (32) ; and M-cadherin is not as consistent a marker of SCs in humans as it is in mice. Among the more reliable markers of SCs in human muscle is CD56, although it also marks natural killer lymphocytes (33) .
Activation. In response to a muscle injury, SCs are activated and start to proliferate; at this stage, they are often referred to as either myogenic precursor cells (mpc) or myoblasts (34, 35) . Several signals, deriving both from damaged fibers and infiltrating cells, are involved in SC activation, including HGF (36), FGF (37) , IGF (38), and NO (39) .
The progression of activated SCs toward myogenic differentiation is mainly controlled by Myf5 and myogenic differentiation 1 (MyoD) (17) and is followed by fusion into regenerating fibers. The whole process takes approximately 7 days in the mouse (40) , during which time SCs undergo different fates, giving rise to a few Pax7 + MyoD -cells, which return to quiescence (to maintain the progenitor pool), and many Pax7 + MyoD + cells, which are committed to differentiation (41) (Figure 1 ). Notch signaling is thought to regulate this process through promotion of asymmetric divisions, although there is not agreement on the role of Numb (a Notch inhibitor and cell-fate determinant) in inducing differentiation (42) and sustaining self renewal (43) . The occurrence of asymmetric cell division is also supported by the identification of a subpopulation of SCs able to retain BrdU after pulse-chase labeling, with some cells displaying selective template DNA strand segregation during mitosis (43, 44) . In addition, Rudnicki and colleagues validated the label-retention model of SCs and demonstrated that approximately 10% of Pax7 + mouse SCs had never expressed Myf5 and that these cells remain adherent to the basal lamina during asymmetric mitosis, generating one Pax7 + Myf5 -satellite "stem cell" and one Pax7 + Myf5 + SC "progenitor," eventually destined to differentiate (25) (Figure 1 ). The same group also elegantly described Wnt7a as regulating the symmetric expansion of Pax7 + Myf5 -SCs (45) .
Transplantation. Because of their features, SCs were considered obvious candidates for a cell-therapy approach to treating muscular dystrophy. Pioneer studies demonstrated that intramuscular injection of normal myoblasts (46) into mdx mice, which lack dystrophin and are a model for DMD, resulted in fusion with host fibers and extensive dystrophin production. These studies led to several clinical trials in the early 1980s (see Muscular dystrophies section for details) that failed for a number of reasons, including poor survival and migration of donor cells after transplantation and rejection of the donor cells due to an immune response by the patients (47) .
Many subsequent preclinical studies aimed to improve the survival, proliferation, and differentiation of the SCs after engraftment. For example, transplantation in dystrophic mouse mus-
Figure 1
Asymmetric cell division during activation of SCs. This is a drawing representing the anatomy of a muscle fiber with adjacent small vessels. SCs and other myogenic cells (pericytes and hematopoietic, endothelial, and interstitial cells) are depicted. SC activation in vivo is followed by an asymmetric division, with Pax7, MyoD, and Myf5 being expressed in differentiating cells and Pax7 in cells returning to quiescence in order to maintain a pool of progenitors (25, 41) . review series cles of a single muscle fiber that contained as few as seven SCs led to an increasing number of new SCs that in turn generated more than 100 new muscle fibers and could also be activated after injury (48) . This is a much more efficient way to generate new muscle fibers than transplantation of cultured SCs, in which normally the number of donor-derived new fibers that are generated is several orders of magnitude less than the number of injected cells. Unfortunately, this method would be difficult to translate into clinical protocols.
In the past few years, several groups have succeeded in prospectively isolating "pure" populations of SCs by using a combination of different markers (Table 1) , such as Pax3-GFP (30), CXCR4 and β 1 integrin (49), α 7 integrin and CD34 (50), or syndecan-3 and -4 (51) . It is still unknown whether the different protocols allow isolation of the same cell population, enriched to different extents for a more primitive "stem-like" fraction. However, all these studies revealed that freshly isolated cells have a much greater capacity to generate dystrophin-expressing fibers in mdx mice than the same cells after in vitro expansion (30) ; the simplest explanation for this is that the "stem" fraction either dies in culture or generates differentiation-committed SCs. Importantly, a short culture period of 3-4 days, without subculture, allowed lentiviral-mediated transduction and thus genetic correction of SCs freshly isolated from mdx mice, without compromising myogenic potency in vivo (52) . Despite these encouraging results, previous unsolved problems still prevent the use of SCs to systemically treat patients with muscular dystrophy: in particular, the inability of these cells to cross the endothelial wall makes systemic delivery impossible and prevents possible healing of the diaphragm and cardiac muscles, both critical for patient survival (34) .
Other myogenic progenitors
The availability of cell-autonomous, tissue-specific transgenic markers allowed the unequivocal demonstration of the existence of myogenic progenitors originating from tissues other than skeletal muscle (53) . Upon transplantation (either BM transplantation [BMT] or direct injection into skeletal muscle), these cells, identified by transgene expression, participate in muscle regeneration in wild-type and/or dystrophic mice (Figures 1 and 2 ; Table 2 ) and eventually enter the SC pool. The possibility that myogenic differentiation may depend upon fusion (and hence exposure to the dominant activity of MyoD) remains, but for skeletal muscle, this would be part of the physiological mechanism that creates the tissue. Below, we describe briefly some examples of these unorthodox myogenic cells. (54) . Interestingly, cells expressing Myf5 exist in the brain and spinal cord, suggesting a cryptic potency that becomes apparent in vitro (55) .
Hematopoietic cells. The first evidence of in vivo generation of skeletal muscle from BM cells was reported in 1998 (56) in a study that used transgenic mice expressing a nuclear LacZ under the control of the striated muscle promoter myosin light chain 1/3 fast (MLC3f). After transplantation of BM from the transgenic mice and subsequent injury to the host muscle, unequivocal β-gal-positive nuclei were detected in regenerated fibers, demonstrating that murine BM contains transplantable progenitors that can be recruited to an injured muscle through the circulation, where they participate in muscle repair (56) . This opened the possibility of treating muscular dystrophy by BMT, but work in mice indicated that, unfortunately, the frequency of this event was too low, even in a chronically regenerating dystrophic muscle and even if the side population (SP) progenitor-enriched fraction was transplanted (57, 58) . To address this issue, subsequent experiments were directed to identifying a rare, potentially highly myogenic progenitor, but those studies have so far had modest success. The hematopoietic, CD45 + fraction of the BM has been identified as the cell population with myogenic potential (59) , and retrospective analysis in a DMD patient that had undergone BMT confirmed the persistence of donorderived skeletal muscle cells over a period of many years, again at very low frequency (60) . Together, these data suggested that HSCs or a yet-to-be-identified cell that expresses several markers in common with true HSCs has myogenic potential. More recent approaches confirmed that hematopoietic cells have myogenic potential but disagreed on the stage at which myogenic differentiation would occur. One study reported that the progeny of a single mouse hematopoietic progenitor cell can both reconstitute the hematopoietic system and contribute, at low frequency, to muscle regeneration (61) . However, a similar study showed that in response to injury, CD45 + hematopoietic progenitors contribute to regenerating mouse skeletal muscle through fusion of mature myeloid cells rather than fusion of the HSCs (62) .
A subpopulation of circulating cells expressing CD133 (also known as Ac133), a well-characterized marker of HSCs, also expresses early myogenic markers (63) . When injected into the circulation of dystrophic scid/mdx mice, CD133 + cells have been found to contribute to muscle repair, recovery of force, and replenishment of the SC pool. The group that discovered this also isolated a population of muscle-derived stem cells (MDSCs) expressing CD133 (64) . Furthermore, when CD133 + cells from DMD patients were genetically corrected by lentivirus-mediated exon skipping for dystrophin exon 51, these cells were able to mediate morphological and functional recovery in scid/mdx mice (64) . Thus, different subpopulations of hematopoietic cells, whose characterization is still incomplete, seem to possess myogenic potency, but none of these exhibit this property at high frequency.
Cells derived from mesoderm (other than hematopoietic cells). Many different types of mesoderm stem/progenitor cells have been shown to exhibit myogenic potential, usually after drug treatment, genetic modification, or coculture with SCs or myoblasts. In some cases, evidence of in vivo myogenesis has been documented. The list of such cells includes mesenchymal stem cells (MSCs), multipotent adult progenitor cells (MAPCs), MDSCs, CD133 + cells, mesoangioblasts (MABs), endothelial progenitor cells (EPCs), and adipose-derived stem cells, all of which are briefly described below or in Table 2 . More details can be found in previous reviews (6, 32) . 
review series
MSCs have been shown to be capable of skeletal myogenesis (65) . However, recently, Perlingeiro and colleagues demonstrated that although Pax3 activation enabled the in vitro differentiation of murine and human MSCs into MyoD + myogenic cells, these cells failed to cause functional muscle recovery in mdx mice, despite good engraftment (66) . The reason for this failure remains unclear.
MABs are vessel-associated progenitors (67) that express early endothelial markers when isolated from the embryo and pericyte markers when isolated from postnatal tissues. Since MABs are able to cross the vessel wall and are easily transduced with lentiviral vectors, they have been used in preclinical models of cell therapy for muscular dystrophy. Intraarterial delivery of either wild-type or genetically corrected MABs morphologically and functionally ameliorated the dystrophic phenotype of mice lacking α-sarcoglycan (Sgca), which model limb-girdle muscular dystrophy 2D, a muscular dystrophy caused by mutations in the SGCA gene (68) . In addition, intraarterial delivery of wild-type postnatal canine MABs resulted in extensive recovery of dystrophin expression and ameliorated pathologic muscle morphology and function in golden retriever dogs that model DMD (69) . Similar cells have been isolated from human postnatal skeletal muscle and shown to represent a subset of pericytes and to give rise to dystrophin-positive muscle fibers when transplanted into scid/mdx mice (70) . Based on these studies, a phase I clinical trial with MAB allotransplantation in DMD patients is planned for the near future.
Initially identified as circulating cells expressing CD34 and fetal liver kinase-1 (Flk-1; also known as VEGFR2), EPCs (71) were shown to be transplantable and to participate actively in angiogenesis in various physiologic and pathologic conditions (71) . It was then shown that freshly isolated human cord blood CD34 + cells injected into ischemic adductor muscles gave rise not only to endothelial but also to skeletal muscle cells in mice (72) . Consistent with this, Péault and colleagues have identified cells with high myogenic potential within the vascular endothelium of human adult skeletal muscle (73) . These human myoendothelial cells, which represent less than 0.5% of the cells in dissociated adult skeletal muscles, expressed both myogenic and endothelial cell markers (CD56 + CD34 + CD144 + CD45 -), exhibited long term proliferation, had a normal karyotype, and when transplanted into scid mice, were able to regenerate fibers in injured muscle (73) .
Human multipotent adipose-derived stem (hMADS) cells, isolated from adipose tissue, differentiate into adipocytes, osteoblasts, and myoblasts (74) . Recently, the myogenic and muscle repair capacities of hMADS cells have been enhanced by transient expression of MyoD (75) . The easy availability of their tissue source, their strong capacity for expansion ex vivo, their multipotent differentiation, and their immune-privileged behavior suggest that hMADS cells could be an important tool for cell-mediated therapy for skeletal muscle disorders.
PSCs for muscle regeneration
PSCs can give rise to all cell types. Among the various PSCs, we limit our discussion to ES cells (76, 77) and induced pluripotent stem (iPS) cells (78) , as they are, in practice, the two types of PSC most commonly used to direct differentiation toward a given cell type, skeletal muscle, for the purpose of this Review. PSCs hold tremendous hopes for the cell therapy of degenerative diseases; and iPS cells further offer the possibility of deriving patient-specific PSCs (79) to study diseases in vitro (80) and the potential for genetic correction for autologous cell therapy.
Turning PSCs into skeletal muscle. A critical step in establishing the potential of PSCs as a therapeutic for skeletal muscle diseases is the development of techniques for the differentiation of these cells into tissue-specific progenitors suitable for transplantation. The most elegant way to obtain specific transplantable cell types is by exposing them in vitro to the same molecules that control their in vivo commitment during embryogenesis (reviewed in ref. 81) , although the empirical testing of molecules and substrates could generate equally useful cells.
Seminal studies from the mid-1990s described how ES cellderived embryoid bodies (EBs), tridimensional structures formed when ES cells are grown in the absence of an embryonic fibroblast feeder layer, contained multinucleated muscle fibers that express skeletal muscle myosin heavy-chain genes (82, 83). Ten years later, it was documented for the first time in vivo that intramuscular injection of mouse EBs cocultured with mdx muscle-derived progenitors in mdx mice led to the production of a few clusters of donor-derived dystrophin-positive fibers (84). Recently, Studer and coworkers have derived transplantable myoblasts from human ES cells (85), while Chang and colleagues have generated transplantable satellite-like cells from mouse ES cells (86). Upon transplantation into mdx mice, the latter cells have been found to regenerate acutely and chronically injured muscle and could also be secondarily transplanted (86). MyoD-mediated myogenic conversion of ES cell-derived cells is another intriguing approach, 
Muscle regeneration from ES/iPS cells via mesodermal progenitors.
There is a large body of evidence indicating the existence of nonconventional muscle progenitors (see Other myogenic progenitors). Thus, the possibility of deriving mesodermal myogenic progenitors (89) from ES/iPS cells offers an alternative route for cell therapy for skeletal muscle regeneration. This approach has the advantage of producing myogenic progenitors that could be delivered systemically through the circulation.
In 2005, Studer and colleagues described the derivation from ES cells of mesenchymal precursors (90) that differentiated in vitro into different mesodermal lineages, including skeletal muscle. A recent article described the derivation from mouse ES cells of PDGFRα + mesodermal progenitors that, after in vivo transplantation, expressed markers of SCs and contributed to muscle regeneration (91).
Issues to be solved. Despite the excitement for these novel strategies for treating degenerative muscular conditions, a number of safety and efficacy issues, some common to other cells (immunogenicity, survival, and differentiation), some prominent for ES/iPS cells, such as tumor formation, still need to be solved. For example, cytofluorimetric purification of committed progenitors (88) may dramatically decrease the possibility of transplanting undifferentiated tumorigenic cells. The use of standardized protocols for generating iPS cells (92), together with stringent tumorigenic assays for the derived cell types, will certainly be a fundamental step toward their clinical application.
Skeletal muscle stem cells: past and ongoing clinical trials
Until now only SCs, and, to a very minor extent, CD133 + cells have been used in human clinical trials. The pathologies treated include forms of muscular dystrophy, heart failure associated with myocardial infarction (HFMI), and stress urinary incontinence (SUI).
Muscular dystrophies. In 1990, Peter Law and collaborators reported the first SC transplant in a 9-year-old boy affected by DMD, showing safety and dystrophin production (93). Soon after, 11 clinical trials in DMD patients were conducted using intramuscular injection of SCs (Table 3 ) (94-104). Although there were no adverse effects, new dystrophin production was demonstrated in many but not all cases and clinical benefit in none (6, 105) . This is not surprising considering that intramuscular injection in several locations of a single muscle (or at most a few muscles) cannot elicit a general effect, although improved strength of the injected muscles was detected in 15% of the patients treated. Treating muscular dystrophies by intramuscular injection of myoblasts presents several problems that have not been solved yet. First, intramuscular injected cells distribute locally, implying that a huge number of injections will have to be performed in order to treat a complete muscle (96). Second, immune responses toward the injected SCs have been described, even in the case of major histocompatibility locus coincidence. Finally, the rapid death of most of the SCs in the first 72 hours after injection has been extensively reported (106, 107). Subsequent experimentation has been devoted to solving these problems, and a phase I clinical trial has been com- Heart failure. Among different options to treat heart infarction, skeletal muscle-derived myoblasts were considered an optimal cell therapy, as they can be easily obtained from the same patient (avoiding the need for long-term immune suppression), rapidly expanded in vitro, and transplanted back in the patient heart. Preclinical experiments performed in animal models demonstrated their ability to engraft correctly, survive in postinfarction scars, differentiate into contractile skeletal muscle cells, and improve heart function (109-111), possibly also because they release angiogenic factors. Unfortunately, in these models, myoblasts were not able to differentiate into cardiomyocytes and did not integrate electrically with the host cardiomyocytes (112, 113) . Despite this significant problem, several nonrandomized clinical trials using myoblasts to treat the infarcted heart demonstrated thickening of the LV, an increase in LV ejection fraction, and prevention of LV dilatation, with clinical improvement in some patients (114-120). Histological analysis showed the presence of new myofibers in the scar zone expressing skeletal muscle-specific myosin heavy chain (121). In general, the transplantation procedure was clinically well tolerated, but a high incidence of arrhythmias, some of which were fatal, was reported. In 2007, the results of the MAGIC study, an international phase II double-blind trial were published (122). Ninety-seven patients affected by HFMI were randomized to receive placebo, a low dose of myoblasts (400 × 10 6 cells), or a high dose of myoblasts (800 × 10 6 cells). LV end-diastolic volumes decreased substantially in patients receiving myoblasts, supporting a role for myoblasts in remodeling of the heart muscle. The incidence of secondary events, including arrhythmias, was not different between the groups, although all patients received the antiarrhythmic agent amiodarone and were implanted with a cardioverter defibrillator. The results of the CAuSMIC (123) and SEISMIC trials (124) have demonstrated safety and some clinical improvement. Ongoing trials include the MARVEL study, a phase II/III randomized, double-blind, placebo-controlled trial for which results are expected during the fall of 2009.
SUI. SC-derived myoblasts have also been used as cell therapy for individuals with SUI, which is characterized by the loss of small amounts of urine upon coughing, laughing, sneezing, exercising, or other movements that increase intraabdominal pressure. Myoblasts may represent an interesting approach for the treatment of this disease (125), as the main cause of SUI is impaired tone of the urethral smooth and striated muscle, which is associated with atrophy of the supporting structures of the urethra, the mucosa, and vascular submucosa (126, 127) . Treatment of SUI with SC-derived myoblasts has been performed using two different strategies: injection of autologous myoblasts to improve the sphincter tone; and injection of myoblasts together with fibroblasts (isolated by differential adhesion from the same muscle biopsy) to both improve sphincter tone and treat mucosa atrophy. Until now, all published studies have been nonrandomized, open studies, demonstrating a remarkable clinical improvement in most of the patients treated (127, 128). Moreover, structural and functional techniques have demonstrated thickening of the urinary sphincter and an increase in maximum urethral closure pressure. The onset of improvement is not immediate and may be delayed up to six months after cell injection; however, the benefit, once obtained, lasts for a long period of time, at least up to 12 months (126). Cystoscopic studies have not demonstrated overgrowth of myoblasts nor obstruction of the lower urinary tract (129). Unfortunately, these successful results have not been confirmed yet in a randomized study.
Conclusions
This is an exciting period for those studying the biology of skeletal muscle stem cells and seeking to harness the information for clinical applications. By learning more about SCs and other mesodermal skeletal muscle progenitors, we can learn how to better use them to repair muscle. The main limitations of SCs are loss of "stemness" upon culture and an inability to cross the vessel wall for systemic delivery. Limitations for other cell types are incomplete characterization and their overall minor myogenic potency. Nevertheless, a phase I clinical trial with donor-derived MABs is planned for the end of 2010, given the fact that, because of extensive preclinical work, these cells appear at the moment as the best candidates for the cell therapy of muscular dystrophy. Moreover, the terrific prospective of deriving countless autologous, genetically corrected iPS cells from patients certainly will set the stage for future cell therapies. Finally, we should remember that SCs have already been used for clinical trials for DMD, myocardial infarction, and SUI. The last seems to be a case of success for this approach and a situation from which we may also learn in order to redirect efforts toward therapies for myocardial infarction and muscular dystrophies, which have thus far been less successful. It has been 50 years since Mauro 1 first postulated that satellite cells could be resident progenitor cells involved in skeletal muscle regeneration. Satellite cells were initially characterized according to their anatomica l position as sublaminar mononuclear cells 'wedged' between the basal lamina and the plasma membrane (also known as the sarcolemma in this context) of myofibres. Within this niche, satellite cells are commonly adjacent to a myonucleus of their host myofibre and an endothelial cell of a nearby capillary. The close proximity of satellite cells to myofibres suggested that they may have a role in muscle regeneration.
Since the discovery of satellite cells, evidence has accumulated showing that they are the primary contributors to the postnatal growth, maintenance and repair of skeletal muscle. In adult muscle, satellite cells express the transcription factor pairedbox 7 (PAX7) (FIG. 1a) and remain quiescent under normal physiological conditions 2, 3 . Readily responsive to molecular triggers from exercise, injuries or disease, satellite cells have a remarkable ability to self-renew, expand, proliferate as myoblasts or undergo myogenic differentiation to fuse and restore damaged muscle 4 (FIG. 1b) . Most importantly, satellite cells are maintained through repeated cycles of growth and regeneration, which supports the notion that they are a heterogeneous population containing stem cells that sustain their self-renewal.
Recent studies using transgenic mice have further examined the role of satellite cells during postnatal regeneration and in hypertrophy. In this Opinion article, we focus on the evidence that satellite cells are essential during these processes, describe the mechanisms maintaining their homeostasis through many rounds of regeneration and discuss findings showing that PAX7 is required to specify this lineage.
Myogenesis
Many similarities between the activation of satellite cells and myogenesis in the somite (BOX 1) have reinforced the idea that adult muscle regeneration to a certain extent re capitulates embryonic development through analogous, but not necessarily identical, mechanisms. Below, we briefly introduce the genetic networks involved in myo genesis -for recent, comprehensive reviews on myogenesi s, see Myogenic regulatory factors. Similarly to the establishment of embryonic progenitors in the myotome (BOX 1) , the activation of satellite cells into myoblasts involves the upregulation of the basic helix-loop-helix (bHLH) transcription factors myogenic facto r 5 (MYF5) and myoblast determination protein (MYOD) (FIG. 1b) . Together with musclespecific regulatory factor 4 (MRF4; also known as MYF6) and myogenin, which are upregulated during myoblast differentiation, these myogenic regulatory factors (MRFs) transcriptionally and epigenetically determine the myogenic capacity of muscle progenitors 7 . Mice lacking MyoD have seemingly normal muscle but express about fourfold higher levels of MYF5 (REF. 8 ). MYF5-deficient animals also have normal muscle 9, 10 . However, mice lacking both Myf5 and MyoD are totally devoid of myoblasts and myofibres 11, 12 , indicating that these genes are required for the determination of myogenic precursors. Although MRF4 has some capacity to function as a determination factor 12 , it is has not been established that it does so in the presenc e of MYF5 and MYOD.
As a downstream target of MYOD, myogenin regulates the transition from myoblasts into myocytes and myotubes (FIG. 1b) and, although myogenin-knockout mice show proper compartmentalization of muscle groups, they almost completely lack myofibres and accumulate undifferentiated myoblasts 13, 14 . Mice lacking both MyoD and Mrf4 display a phenotype that is similar to the myogenin-null phenotype, suggesting that, for myoblasts only expressing MYF5, the differentiation into myocytes requires MRF4 (REF. 15 ). Thus, MYF5 and MYOD are required for the determination of myogenic precursors and act upstream of myogenin and MRF4, which are required for terminal differentiation 11 . Together, these findings suggest that various overlapping regulatory networks control myogenic differentiation.
PAX3 and PAX7 specify myogenic progeni tors. The expression of MRFs is regulated by PAX3 and PAX7, both of which have been shown to directly bind proximal promoters of MyoD and distal enhancer elements of Myf5, thereby regulating their expression [16] [17] [18] . PAX3 and PAX7 play key parts in maintaining the proliferation of progenitors and preventing early differentiation. Moreover, ectopic expression of Pax3 or Pax7 in mouse embryonic stem cells showed that either one is sufficient to promote a myogenic fate 19 . Abstract | Satellite cells are a heterogeneous population of stem and progenitor cells that are required for the growth, maintenance and regeneration of skeletal muscle. The transcription factors paired-box 3 (PAX3) and PAX7 have essential and overlapping roles in myogenesis. PAX3 acts to specify embryonic muscle precursors, whereas PAX7 enforces the satellite cell myogenic programme while maintaining the undifferentiated state. Recent experiments have suggested that PAX7 is dispensable in adult satellite cells. However, these findings are controversial, and the issue remains unresolved. Belonging to the PAX family of transcription factors, PAX3 and PAX7 are paralogues with conserved amino acid sequences and have almost identical sequence-specific DNA-binding motifs 20 . Despite this homology, studies using knockout mice suggest that PAX3 and PAX7 have overlapping roles only in myogenic specification; the distinct phenotypes of these mice indicate that PAX3 has unique functions during embryonic development 21 and that PAX7 is involved in the specification of satellite cells 2 . PAX3-null mice (also known as splotch mice) have many developmental defects, including a lack of limb muscles and reduced MYOD expression in the myotome 22 
Interestingly, mice lacking both PAX3 and MYF5 cannot upregulate MYOD to compensate for the lack of MYF5 and thus lack muscle 23 , which further indicates that PAX3 activates MYOD 16 . Even though PAX3 is expressed at an earlier embryonic stage than PAX7, PAX7 is upregulated in PAX3-null mice, presumably to compensate for the loss of PAX3 (REF. 22 ). In fact, muscle formation requires PAX3 or PAX7, as progenitor cell populations from mice lacking both Pax3 and Pax7 undergo apoptosis, and these mice do not form muscle 24 . Although Pax7 knock-in at the Pax3 locus can rescue the PAX3-null phenotype during somitogenesis, it does not fully rescue the lack of delamination and long-range migration of muscle progenitors to the limb bud, which requires the activation of hepatocyte growth factor receptor (HGFR; also known as MET) by PAX3 (REFS 21, 25) 
. This suggests that PAX3 is solely responsible for the migration of progenitors to establish myogenic compartments within the limb.
By contrast, PAX7 seems to be uniquely required in satellite cells (discussed in detail below). Indeed, PAX3 is downregulated postnatally in most muscle progenitors, except for the satellite cells of a subset of muscle groups such as the diaphragm 25 , whereas PAX7 expression is maintained in all satellite cells 2 . Furthermore, PAX7-null mice have normal embryonic myogenesis but lack functional satellite cells 2 . Together, these findings argue that PAX3 and PAX7 have overlapping but non-redundant roles in the myogenic programme. . However, these studies have not conclusively ruled out the possibility that satellite cells are a distinct myogenic lineage, independent from those that give rise to fetal myoblasts, or that they arise from atypical myogenic stem cells in postnatal muscle (BOX 2) .
Specification of satellite cells
Relative roles of PAX3 and PAX7 in satellit e cells. PAX7 expression is maintained in all satellite cells and proliferating myoblasts but is sharply downregulated before differentiation 29 . PAX3 and PAX7 co-expression in adult satellite cells seems to be limited to only a few muscle groups -mostly the diaphragm and body wall muscles 25 . Although PAX3 expression is robust in the embryo, its downregulation after birth suggests that it has little function in most satellite cells. Prolonged expression of PAX3, by preventing its proteosomal degradation, results in the inhibition of terminal differentiation 30 , consistent with the ability of ectopically expressed PAX7 to inhibit differentiation 29 . This result has been used to argue that PAX3 regulates satellite cell activation. Although studies have indicated a role for PAX3 in satellite cell development and mainten ance 30, 31, 32, 33 , this currently remains controversial.
By contrast, PAX7 is required for the development and maintenance of satellite cells. Indeed, cells found in the satellite cell positions of PAX7-null mice are not myogenic and do not express satellite cell markers (such as syndecan 4 and CD34; see below) 31 . Importantly, although rare PAX3 + myogenic cells are observed in PAX7-null mutants, PAX3 cannot compensate for the loss of PAX7 in the establishment of the satellite cell lineage. Moreover, although satellite cells in the diaphragm normally express abundant PAX3, the phenotype of PAX7-null satellite cells that express PAX3 in the diaphragm is identical to other muscle groups: they cannot maintain the undifferentiated state, they fuse into myofibres early or they have reduced survival, ultimately compromising their capacity for muscle growth and regeneration 2, 25, 31, 34, 35 . This suggests that PAX3 alone is insufficient to rescue these cells 2, 32 . Two possible functions have been proposed for PAX7 in the specification of satellite cells: the specification of the myogenic identity and the maintenance of the undifferentiated state. Ectopic overexpression of PAX7 in C2C12 myoblasts and primary myoblasts suggests that PAX7 drives the expression of Myf5 but not MyoD 18, 29 . Furthermore, PAX7 has been shown to directly activate Myf5 by promoting the recruitment of the ASH2-like (ASH2L)-MLL2 histone methyltransferase complex at a regulatory element 57 kb upstream of the Myf5 coding region 18 , which indicates that PAX7 can epigenetically specify the myogenic identity of satellite cells. However, PAX7 expression correlates with an undifferentiated but committed myogenic state 36 , which suggests that PAX7 in the early postnatal period probably functions to prevent the transition into terminal differentiation while maintaining the myogenic identity by promoting MYF5 expression. Both functions together allow PAX7 to specify the satellite cell lineage.
Requirement for PAX7 in satellite cells.
Recently, a study by Lepper et al. 35 using an inducible knockout mouse strain lacking PAX7 specifically in satellite cells when injected with tamoxifen challenged the proposed requirement for PAX7 expression in adult satellite cells. Interestingly, when postnatal time points were examined, the phenotype of mice in which Pax7 had been deleted between postnatal day 7 (P7) and P21 was the same as that of the previously characterized PAX7-null mice 2, 25, 31, 34, 35 . This result confirms a crucial function for PAX7 during postnatal growth, and this is further supported by the observed early fusion of progenitors in PAX7-null mice and the conversion of fetal cells from conditional PAX7-knockout mice into fibroblasts 35 . Surprisingly, induced ablation of both Pax3 and Pax7 after P21 did not lead to any deficiency in muscle regeneration, satellite cell number or primary myoblast growth or differentiation 35 . This suggests a rather dramatic change in the genetic requirement of muscle regeneration around P21, the time point when myonuclear accretion is completed (see below) and when postnatal growth is thought to end and satellite cell numbers to reach a steady state 37 . The distinct regeneration phenotypes obtained by PAX7 deletion between P7-P21 and adulthood challenge the notion that PAX7 is required throughout adulthood to activate downstream MRFs. It remains unclear whether satellite cells are poised for activation and extrinsic signalling is sufficient to initiate MRF expression or whether temporal specification by PAX7 is sufficient to maintain satellite cell identity after P21. The temporal specification hypothesis is supported by the finding that tamoxifeninduced knockout of Pax7 leads to loss of myogenic identify in fetal cells but not adult cells 35 . One possibility is that the epigenetic function of PAX7 in recruiting ASH2L-MLL2 to target genes has been completed by P21 and that target genes that define myogenic identity are capable of maintaining their epigenetic memory in the absence of PAX7.
However, the ability of satellite cells to function after P21 without PAX7 is difficult to reconcile with the published literature. For example, in vitro knockdown of Pax7 in any aged myoblast or satellite cell has been shown to result in growth arrest and marked reduction in MYF5 expression 18, 34 . Why would a knockdown of PAX7 but not a deletion affect satellite cell maintenance? The notion that proliferating myogenic cells have become 'addicted' to PAX7 might be considered; that is, that continued PAX7 expression might be required to keep the cells in a proliferative state. Another interesting possibility is that the floxed allele analysed by Lepper et al. is a hypermorph that is expressing a truncated but functional PAX7 lacking a paired domain.
Box 1 | Embryonic myogenesis
Early embryonic myogenic precursors giving rise to body wall muscles are marked by paired-box 3 (PAX3) expression in the paraxial mesoderm 67 . At this early stage, PAX3 + progenitors are multipotent and give rise to the dorsal dermis and vascular progenitors of the aorta 68 . Morphogens expressed by surrounding embryonic structures eventually determine the cellular commitment within the somites (mesodermal structures found on either side of the neural tube in vertebrate embryos that eventually give rise to muscles, skin and vertebrae) 69 . Sonic hedgehog signalling from the notochord acts on the ventral medial segment of the somite and leads to the formation of the sclerotome, which contains precursors to bone and cartilage 70 . WNT signalling in the dorsal portion of the somite leads to the retention of an epithelial morphology and the formation of the dermomyotome 71 . Combined expression of PAX3 and PAX7 in the dermomyotome further specifies progenitor cells towards the muscle lineage, but transient Notch activation from neural crest cells is required before the expression of myogenic regulatory factors (MRFs; which define muscle progenitors) 22, 24, 72 . Notch signalling is essential for retaining myogenic progenitors in a proliferative state; however, its downregulation is required to allow progression into terminal differentiation. MRF + progenitors migrate and proliferate to give rise to the myotome, in which cells downregulate PAX3 and PAX7 to undergo differentiation and form primitive nascent myofibres 21, 24, 26 . These primitive myofibres act as templates for the formation of additional myofibres during postnatal growth.
The development of limb muscles requires the establishment of myogenic compartments in the limb bud. This process involves the delamination and migration of progenitors from the dermomyotome 73 . Induction of hepatocyte growth factor (HGF) in the limb bud activates myogenic progenitors expressing HGF receptor (HGFR; also known as MET), which delaminate from the ventrolateral lip of the dermomyotome. PAX3, and not PAX7, is able to induce the expression of HGFR in embryonic progenitors 25 . Thus, PAX3 is required to activate the long-range migration of progenitors to the limb bud. This is consistent with the lack of limb muscles in PAX3-null mice 21 .
If PAX7 is required only in the specification of new satellite cells, such a defect would become apparent only after several rounds of regeneration, when satellite cell pools have become exhausted. Moreover, this defect can be masked by alternative mechanisms of selfrenewal in satellite cells, such as reversible quiescence (see below).
Nevertheless, Lepper et al. 35 challenged the paradigm that PAX7 is crucial for satellite cells in adults. Thus, further analysis is needed to elucidate the requirement and function of PAX7 in adult satellite cells.
Satellite cells in postnatal life
After postnatal growth (~P21), maturation of skeletal muscle slowly reaches a homeostasis of rest and regeneration. Satellite cells also enter quiescence as their numbers decrease dramatically from ~30% of sublaminar nuclei to <5% by 8 weeks, which reflects fusion into myofibres, a process known as myonuclear accretion 37, 38 . This entry into quiescence was recently shown to depend on Notch signalling, as mice lacking two Notch targets, Hairy and Enhancer of Split-related 1 (HESR1) and HESR3, fail to generate quiescent satellite cells 39 . Inhibition or disruption of Notch signalling in quiescent satellite cells leads to their early differentiation and fusion 40, 41 , similarly to what is observed in PAX7-null mice.
Originally defined by their anatomica l position to the host myofibre 1 , quiescent satellite cells are reliably identifiable by the expression of molecular markers, such as PAX7, α7β1 integrin, CD34, syndecan 3, syndecan 4, myotubule cadherin (M-cadherin), caveolin 1 and CXC chemokine receptor 4 (CXCR4; also known as fusin and CD184) 42 . The identification of these markers, as well as the generation of transgenic reporter mouse lines, has only recently allowed the prospective isolation and characterization of satellite cells in their quiescent state 28, 43 . Satellite cells are heterogeneous. All adult satellite cells express PAX7, and this expression is conserved through evolution 42 . However, subpopulations of satellite cells express a mixture of different surface markers as well as altered expression levels of MYF5 and MYOD 44 . Because satellite cells are self-renewing, within this heterogeneity there must be a stem cell-like population that is resistant to differentiation and maintains the satellite cell pool through many rounds of regeneration. Experiments have shown that small fractions (~20%) of satellite cells have slower proliferation kinetics and can resist differentiation 45 . Furthermore, satellite cells from different muscle groups also display differential engraftment potential after transplantation 46 . In these transplantation experiments, only a small fraction of satellite cells shows stem cell-like properties and engrafts into the satellite cell compartment.
PAX7 +

MYF5
-satellite stem cells. Using lineage tracing in a mouse strain in which cells that have expressed MYF5 are permanently labelled with yellow fluorescent protein (YFP), we identified that ~10% of adult satellite cells express PAX7 but not YFP, indicating that they have never expressed MYF5 (PAX7   +   MYF5 -cells) 28 (FIG. 1a) (FIG. 2a) . The asymmetric nature of the satellite cell niche, with the basal lamina acting as the basement membrane and the sarcolemma of the host myofibre as the apical surface, determines the cell fate of stem cell divisions according to the orientation of the mitotic axis in relation to the host fibre. During in vivo regeneration, satellite stem cell divisions in the apicobasal orientation give rise to a committed MYF5 + satellite cell, which is pushed into the apical surface, and a daughter cell, which remains attached to basal lamina and retains the satellite stem cell identity. By contrast, planar divisions of satellite stem cells occur along the host myofibre, after which both daughter cells remain in contact with the basal lamina, symmetrically expand, giving rise to two PAX7 +
-cells. It remains unclear what intrinsic mechanism is responsible for the orientation of divisions and how subsequent events lead to commitment of the apical daughter cell. However, insights into extrinsic regulators revealed that satellite stem cells are similar to embryonic PAX7 +
-cells in the dermomyotome (BOX 1) , in that inhibition of Notch signalling drives satellite stem cells to commit ment and differentiation 28, 33 . Furthermore, WNT signalling is thought to promote symmetric cell divisions by acting through the planar cell polarity pathway 48 . Specifically, WNT7A signalling through Frizzled 7 markedly stimulates the symmetric expansion of satellite stem cells but does not affect the growth of myoblasts or the kinetics of their differentiation (FIG. 2b) . This induces the polarized distribution of the planar cell polarity effector VANG-like 2 (VANGL2), promoting a planar division plane and
Box 2 | Atypical muscle stem cells
Several laboratories have observed that stem cell populations other than satellite cells also have myogenic capacity. These include pericytes, mesangioblasts, side population cells, CD45 + SCA1 + cells and even bone marrow-derived haematopoietic stem cells (HSCs) [74] [75] [76] [77] [78] [79] [80] . Their myogenic specification requires activation by injury or co-culturing with myoblasts; however, even under such conditions, only small fractions of these cells adopt myogenic fates. Paired-box 7 (PAX7) is required for the myogenic specification of CD45 + SCA1
+ cells during regeneration 79 , whereas the myogenic identity of pericytes, side population cells and HSCs can be activated by alternative pathways. Limited engraftment of these cells to muscle is observed in transplantation experiments, but the extent of their contribution during in vivo muscle regeneration will require further lineage-tracing studies. PW1 + interstitial cells (PICs) were recently described as non-satellite cell myogenic progenitors during postnatal muscle growth that can also adopt either vascular or myogenic fates 81 . The myogenic specification of PICs depends on PAX7 and is enhanced by the presence of satellite cell-derived myoblasts, suggesting that the recruitment of PICs depends on community effects. As most newly specified fetal satellite cells also express PW1, and because lineage-tracing experiments suggest that PICs are not derived from satellite cells, it was speculated that PICs could be a postnatal source of satellite cells.
However, in recent analyses of satellite cell-depleted muscle 53, 54 , atypical muscle stem cells could not promote muscle regeneration or replenish the satellite cell pool. This challenges the previous evidence and suggests either that these atypical muscle stem cells have very limited myogenic potential or that they are not recruited during regeneration in this model owing to a lack of paracrine signals from satellite cells (FIG. 3) . The functional participation of atypical myogenic stem cells will need to be studied further. Moreover, the paracrine factors secreted by satellite cells to induce the recruitment of atypical muscle stem cells could be an interesting therapeutic target to modulate regeneration kinetics. Planar cell polarity pathway b therefore symmetric division of the daughter cells. This pathway is thought to regulate the regenerative potential of muscle. In support of this, WNT7A is upregulated during regeneration and increases both the number of satel lite cells and the muscle mass, and muscle lacking WNT7A exhibits a decrease in satellit e cell number following regeneration.
Reversible quiescence. Replenishment of the satellite cell pool requires stem cells to expand but then return to quiescence, a common feature of adult stem cells. This process is very elusive and only applies to a subpopulation of satellite cells, so our current understanding is minimal. In vitro observations of satellite cells on cultured myofibres suggest that a population of MYOD -reserve cells appear in late regeneration and can return to quiescence by sustaining PAX7 expression and resisting differentiation 49, 50 . This could arise from the expansion of a MYOD -population of uncommitted satellite cells or the downregulation of MYOD in proliferating myoblasts. Most PAX7 +
MYF5
-satellite stem cells correlate with this population and do not express MYOD or myogenin in fibre culture 28 . One known mechanism regulating the reversible quiescence of satellite stem cells is mediated by the receptor Tyr kinase TIE2 (also known as TEK) 51 . TIE2 activation by binding of the hormone angiopoietin 1, which is secreted from neighbouring fibroblasts and vascular cells, activates extracellular signal-regulated kinase (ERK) signalling downstream of TIE2. This enhances PAX7 expression and thereby sustains the undifferentiated state, ultimately increasing the number of stem cells reverting to quiescence.
Reversible quiescence of committed myoblast s challenges the paradigm that MYOD, as a determination factor, is an irreversible epigenetic checkpoint in the myogenic programme. For a subpopulation of myoblasts, this reversion was reported to require the activation of Sprouty homologue 1 (SPRY1), a negative regulator of ERK signalling 52 . However, myoblasts un affected in SPRY1 deletion can maintain a reduced, but homeostatic, number of satellite cells through subsequent injuries. This indicates that alternative mechanisms of reversion into quiescence exist. Although contradictory, TIE2-ERK and SPRY1-ERK signalling apply to two distinct cell types at different time points during regeneration. This suggests that temporal regulation of the ERK signalling pathway controls the number of satellite cells returning to quiescence and reveals the possibility of modulating this homeostasis with extrinsic factors.
Satellite cells in regeneration
The main function of satellite cells is to proliferate and differentiate into muscle cells to regenerate muscle during exercise or injury.
Satellite cells are integral to regeneration.
The ability for satellite cells to contribute to myogenesis has been demonstrated in vitro and in vivo. In a series of diphtheria toxininduced ablation experiments, it was revealed that muscle failed to regenerate when PAX7 + satellite cells were depleted [53] [54] [55] . Two different transgenic alleles were used to eliminate PAX7 + satellite cells from muscle, and both led to the same conclusion: no other cell types can rescue the myogenic function of PAX7 + cells during exercise or injury 53, 54 
.
Instead of the formation of myofibres, adipocyte infiltrates expanded in place of muscle 54 . This genetic ablation result resembles the phenotypes of PAX7-null mice and supports the notion that satellite cells are the primary, if not the sole, contributors to muscle regeneration.
Healthy adult muscle has a slow turnover rate, so satellite cells remain mostly quiescent (see above) unless activated by exercise or injury 3 . Consistent with this, ablation of satellite cells in resting conditions does not result in progressive muscle mass loss 54 . However, in degenerative muscle diseases, such as Duchenne muscular dystrophy, chronic regeneration of muscle triggers higher proliferative demand on satellite cells, leading to their eventual depletion 56 . Interfering with the function of satellite cells in a mouse model for Duchenne muscular dystrophy (mdx mice), by either inducing reduced myogenic differentiation (for example, in MYOD-null mice) or reducing the telomere lengths (for example, in mice lacking telomerase mRNA), results in an exaggerated dystrophic phenotype 57, 58 . Together, these experiments suggest that satellite cells are absolutely necessary for regeneration and that satellite cells lost in disease are not replaced by other stem cell sources.
Interactions with other cell types during regen eration. Although satellite cells are the main players in repairing muscle, various other cells types are also recruited during regeneration and can modulate the behaviour of satellite cells by secreting cytokines (FIG. 3) . During the initial phase of regeneration, secretion of pro-inflammatory cytokines by macrophages can induce myoblast entry into terminal differentiation through the p38 kinase-mediated repression of the Pax7 locus 59 . Expansion of resident fibroadipogenic progenitors (FAPs) during regeneration also promotes the termin al differentiation of myoblasts 60 . However, not all signals during regeneration are pro-myogenic. The presence of muscle connective tissue (MCT) fibroblasts expressing T cell factor 4 (TCF4) seems to prevent early differentiation of myoblasts by creating a transitional niche. Reciprocally, myoblasts promote MCT fibroblast . Late in regeneration, newly formed myotubes prevent the adipogenic differentiation of mesenchymal progenitors expressing platelet-derived growth factor receptor-α (PDGFRα) 61 . These interactions give rise to a complex interaction network between satellite cells and other cell types, which allows the extrinsic regulation of satellite cells in regeneration.
Satellite cell requirement in hypertrophy.
Hypertrophy of muscle (that is, an increase in myofibre size resulting from the production of additional contractile proteins) caused by overloading or exercise requires additional myonuclei for protein synthesis. Because myo nuclei are mitotically arrested and cannot replicate within the myofibre to meet such a demand, hypertrophy is commonly associated with the activation of satellite cells 62 , which are thought to proliferate and fuse into existing myofibres. Indeed, classic studies using γ-radiation to inhibit the proliferation of sate llite cells found a dependence on satellite cell, activation in overloading-induced hypertrophy 63 . However, controversy over the specificity of γ-radiation to satellite cells, as well as a better understanding of intrinsic pathways leading to the hypertrophy of myotubes, such as calcineurin and AKT signalling, indicated that further examination is needed 64 . A recent study 65 provided evidence that satellite cells are not required for overloadinginduced hypertrophy and that intrinsic mechanisms within the myofibres can compensate for protein synthesis without additional myonuclei. Specifically, significant hyper trophy was observed in satellite cell-depleted muscles that were exposed to overloading conditions. However, in controls, activation of satellite cells and fusion into myofibres were observed. This indicates that, in a physiological context, satellite cells indeed participate in hypertrophy. It is not surprising that myofibres can undergo short-term hypertrophy without additional myonuclei, but the addition of myonuclei should reduce the 'workload' placed on the existing myonuclei. Importantly, productive hyper trophy resulting from the participation of sate llite cells would be expected to couple tissue mass with appropriate numbers of stem and progenitor cells. Thus, satellite cells are essential to achieve tissue homeostasis and allow growth and repair over the long term.
Concluding remarks 50 years after their discovery, we have solidified the absolute requirement for muscle satellite cells during muscle regeneration and in hypertrophy. Composed primarily of a nucleus and very little cytoplasm, the rege nerative capacity of satellite cells can only be described as remarkable. Indeed, whereas the requirement for satellite cells has been questioned for short-term hypertrophy, it is clear that maintenance of muscle and productive hypertrophy absolutely require satellite cells.
We have only scratched the surface of a complex genetic network that requires intrinsic and extrinsic activation to regulate the myogenic fate of satellite cells. We know that PAX3 and PAX7 regulate the expression of MRFs and are crucial for muscle development, and that early postnatal specification of the satellite cell lineage requires PAX7 to establish an undifferentiated but myogenic state. However, further work is needed to definitively confirm whether PAX7 is required in adult satellite cells.
Within the past two decades, our understanding of satellite cell biology has formed new paradigms for the maintenance and genetic regulation of adult stem cells in general. Without question, our advancing know ledge of satellite cell biology has opened new doors for the development of therapeutics targeting stem cell growth 48 , in vitro expansion of satellite cells 66 and even induction of embryonic stem cells for transplantation 19 as promising avenues for the treatment of patients suffering from degenerative muscle diseases. Figure 1A) . The life-long regenerative capacity of satellite cells implies that they can be robustly and perpetually renewed while maintaining the ability to generate differentiated progeny and suggests that they may represent an adult stem cell population for skeletal muscle. Stem cells are thought to exist in many adult tissues capable of regeneration and are defined by their unique capacity to both self-renew and differentiate. Adult stem cells have been best characterized in the mammalian blood-forming system, where clonogenic, multipotent hematopoietic stem cells (HSC) have been prospectively isolated from bone marrow and demonstrate at the single-cell level the capacity to regenerate the entire hematopoietic system (reviewed in Kondo et al., 2003) . While it is clear that satellite cells likewise contain unspecified precursor cells capable of extensive proliferation and differentiation to generate mature myofibers, to formally establish that they indeed function as adult stem cells, it will be necessary to demonstrate that individual cells within the satellite cell pool maintain both self-renewal and differentiation potential in vivo. Although this clonal analysis is still lacking, as outlined below, multiple lines of evidence from in vitro and in vivo studies do suggest that muscle stem cells are contained within at least a subset of satellite cells.
First, as noted above, satellite cell number and regenerative capacity normally remain nearly constant through multiple cycles of injury and repair, suggesting satellite cell self-renewal. In addition, studies of isolated single myofibers and primary satellite cells maintained in culture have revealed that some cultured sat- In summary, while under particular conditions some cells apparently distinct from satellite cells can contribute to muscle tissue, the preponderance of evidence indicates that the myogenic activity normally responsible for robust adult muscle regeneration is largely restricted to sublaminar CD34 + satellite cells. (Conboy et al., 2003) . Therefore, it seems that Notch is the key age-related determinant of muscle regenerative potential.
Mechanisms of Bone Marrow Contribution to Skeletal
Prospective Isolation of Muscle Precursor Cells
Is the age-related decline in satellite cell regenerative potential intrinsic or dependent on the cell environment? In early muscle transplantation studies, small minced or intact muscle from young or old rodents was transplanted into either young or old muscle beds, and the ability of donor muscle pieces to regenerate in the middle of either young or old host limbs was examined. Amazingly, the efficiency of muscle regeneration was clearly determined in these experiments by the age of the host environment, rather than by the age of the muscle donor (Carlson and Faulkner, 1989; Zacks and Sheff, 1982) . In these important studies, the small transplanted muscle was physically isolated from the host satellite cells, revealing the effects of prevalent local and organismal environments on the regenerative potential of the donor satellite cells.
In more recent studies, the age of the systemic environment likewise dominated over the intrinsic agerelated regenerative properties of satellite cells when the efficiency of muscle repair was examined in young and old mice with a shared blood circulation ( The rejuvenation of aged stem and progenitor cells by the young extrinsic milieu, even in the presence of these age-related changes, suggests the intriguing possibility that the aging of organ stem cells might be regulated extrinsically and that the molecular changes underlying the loss of the tissue-regenerative potential with age can be reversed or overcome if the stem cell niche is young. Future identification of the relevant extrinsic age-related components will be instrumental for therapies aimed at enhancing the regenerative potential of organ stem cells in aged individuals.
Future Avenues and Perspectives
It is quite clear that endogenous skeletal muscle satellite cells associated with myofibers account for most, if not all, physiologic muscle-regenerative potential and likely represent muscle stem cells. Recent advances have allowed a more refined determination of their origin, position in the myogenic cell lineage, and molecular pathways regulating their function. Other avenues of muscle repair, e.g., by bone marrow-derived cells, may exist; however, unambiguous determination of the precise cell types and specific fusion and reprogramming mechanisms involved in this process will be needed in order to establish whether such cells form muscle tis-sue under physiologic conditions or can be used therapeutically. Current advances in our understanding of the cellular and molecular mechanisms regulating cellfate determination and tissue specification during adult muscle repair have indicated a remarkable conservation of developmentally regulated signal transduction pathways, and age-related analysis of these pathways indicates that at least some of them deteriorate in old muscle, causing ineffective tissue repair. The identification of age-related systemic factors that regulate the regenerative capacity of organ stem cells will improve our understanding of aging as a conserved biological process and will help to develop therapies for the enhancement of the regenerative potential often lost in old age or disease.
